Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Dual regulator of TNF-alpha and IL-10 production with potential in chronic inflammatory diseases

Jan. 23, 2001

Neurochem cleared to advance Fibrillex to phase II/III clinical trials in the U.K.

Jan. 19, 2001

Chemokine inhibitors described by Teijin in recent patent

Jan. 18, 2001

Tacrolimus claimed for conditions associated with cartilage damage

Jan. 18, 2001

La Jolla reports that 90% of lupus patients have key antibodies

Jan. 18, 2001

Monoclonal antibodies to alpha1 integrin designed at Biogen for inflammatory disorders

Jan. 17, 2001

Japanese lab presents new series of TNF-alpha production inhibitors

Jan. 16, 2001

Watson's Aslera scheduled for March FDA Arthritis Advisory Committee review

Jan. 16, 2001

Provalis obtains U.K. marketing rights to Pennsaid topical solution

Jan. 12, 2001

Recent patent covers hydroxamic acid-based MMP inhibitors and their therapeutic use

Jan. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.